Board of Directors

Christian Kemp-Griffin
Christian Kemp-Griffin

CEO

Christian is an early investor in CelluComp and is now executive director and CEO. Prior to CelluComp, Christian held the position of CEO at EDUN, a company developing socially responsible and sustainable clothing and owned, in part, by LVMH . Christian has direct experience working with farmers and producing and marketing finished products. Christian has also held senior management positions with Ralph Lauren, Lacoste (Directeur Générale) and Disney Consumer Products (European Licensing Director) and has extensive experience in product development, manufacturing, marketing and licensing. Christian graduated from Princeton University.

Christian is an early investor in CelluComp and is now executive director and CEO. Prior to CelluComp, Christian held the position of CEO at EDUN, a company developing socially responsible and sustainable...

Read More
Dr. Eric Whale
Dr. Eric Whale

Founder and Head of Technology

Eric is a Chartered Scientist, an MBA graduate (Henley), has a Doctorate in the Synthesis and Characterisation of Liquid Crystal Polymers from the University of Reading and is a member of the Royal Chemistry Society. Eric held Postdoctoral Research Fellowships at the University of Reading in the Centre for Polymer Science (Optical switching) and the Centre for Biomimetics (Mutable Collagen), before joining DERA as a Senior Scientist. Eric has also worked as an independent consultant and has run CelluComp from the beginning, along with Dr David Hepworth.

Eric is a Chartered Scientist, an MBA graduate (Henley), has a Doctorate in the Synthesis and Characterisation of Liquid Crystal Polymers from the University of Reading and is a member of the Royal Chemistry...

Read More
Dr. David Hepworth
Dr. David Hepworth

Founder and Head of Technology

David is an engineer who has carried out extensive work in moulding bio-composite materials and has published many articles in this subject, including in the Royal Society of London. David studied for his undergraduate degree in Zoology at the University of Reading where he received 1st class honors. He later received his PhD from the University of Reading where he specialised in the Biomechanics of Genetically Modified Plant tissues. Along with Eric, David has managed and operated the CelluComp business from the beginning.

David is an engineer who has carried out extensive work in moulding bio-composite materials and has published many articles in this subject, including in the Royal Society of London. David studied for...

Read More
Josko Bobanovic
Josko Bobanovic

Board of Directors

Joško joined Sofinnova in 2010 as Partner of the Sofinnova Green Seed Fund dedicated to seed activities in renewable chemistry and bio-energy. Prior to joining Sofinnova he spent eight years in venture capital with iNovia Capital and its fund MSBi Capital in Montreal, Canada. Joško was responsible for cleantech investments at the fund, and focused on seed and early stage investments in cleantech. Prior to that, he created an internet start-up and a software company. Joško holds a BSc. in physics from University of Zagreb, a PhD in physical oceanography from Dalhousie University and an MBA in finance and marketing from McGill University.

Joško joined Sofinnova in 2010 as Partner of the Sofinnova Green Seed Fund dedicated to seed activities in renewable chemistry and bio-energy. Prior to joining Sofinnova he spent eight...

Read More
John Sinclair
John Sinclair

Board of Directors

John is a private investor and was previously VP of research for Fidelity Management and Research Co. While there he led a research team responsible for the strategic direction and priorities of FMR research and spent much of his time investing in India. Prior to that, John worked as a senior equity analyst and director of research for Pioneer Asset Management, Boston. John also held the same job at MA. Montgomery Asset Management based in San Francisco. John completed a Graduate School of International and Public Affairs degree at Columbia University in New York, and did his undergraduate degree at Colgate University. John speaks fluent Japanese and has lived several years in Japan.    

John is a private investor and was previously VP of research for Fidelity Management and Research Co. While there he led a research team responsible for the strategic direction and priorities of FMR research...

Read More
Jan Ramakers
Jan Ramakers

Board of Directors

After graduating in synthetic organic chemistry and biophysical chemistry at the University of Nijmegen, The Netherlands, Jan began his professional career at DSM’s corporate R&D division before moving into marketing and business research. In 1989 he moved to DSM Fine Chemicals as Business Research and Development Manager. In 1996 Jan began with Wood Mackenzie in Edinburgh, Scotland, to set up a consultancy practice in the fine chemicals area. Jan left Wood Mackenzie in 1999 to create his own consulting company and has established Jan Ramakers Fine Chemical Consulting Group. Jan is a member of the Society of Chemical Industry, the American Chemical Society and is a GlobalScot as well as a member of the Investment Group of Chemical Sciences Scotland.

After graduating in synthetic organic chemistry and biophysical chemistry at the University of Nijmegen, The Netherlands, Jan began his professional career at DSM’s corporate R&D division before...

Read More
Carolyn Fritz
Carolyn Fritz

Board of Directors

Carolyn Fritz has over twenty years of experience in building successful biotechnology businesses. From 2004 - 2014, she built Allylix, a synthetic biotechnology company, from a start-up to a successful sale of company.  Prior to that, she built three businesses - a renewable chemical business and a biopharmaceutical contract manufacturing business at Dow Chemical and a specialty canola oil business at Cargill.  

 

Ms. Fritz has been on the Cellucomp board since 2018.  In addition to serving on the Cellucomp board, she is Chairman of the Board of DMC Biotechnologies and is on the board of Athena San Diego.  She previously served on the boards of Allylix, BIO and Innovase.  Ms. Fritz has an M.B.A from the Wharton School of the University of Pennsylvania, an M.S. from George Washington University and a B.S. in Mechanical Engineering from Iowa State University.

Carolyn Fritz has over twenty years of experience in building successful biotechnology businesses. From 2004 - 2014, she built Allylix, a synthetic biotechnology company, from a start-up to a successful...

Read More